cytosine | CAS:71-30-7

We serve cytosine CAS:71-30-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
cytosine

Chemical Name:cytosine
CAS.NO:71-30-7
Synonyms:2(1H)-Pyrimidinone, 4-amino-
Cyt
Cytosinimine
4-aminopyrimidin-2-one
Cytosine
Molecular Formula:C4H5N3O
Molecular Weight:111.10200
 
Physical and Chemical Properties:
Density:0.48
Melting point:>300 ºC
Boiling point:445.8ºC
Flash point:223.4ºC
Index of Refraction:1.688
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥99.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.1%
Heavy metal:≤10ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Mainly used in the synthesis of anti-AIDS drugs and anti-hepatitis B drugs lamivudine, anticancer drugs gemcitabine, enoxabine and 5-fluorocytosine.



Contact us for information like 2(1H)-Pyrimidinone, 4-amino- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cytosine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cytosinimine Use and application,Cyt technical grade,usp/ep/jp grade.


Related News: There are no reliable vaccines available to rid your body of a coronavirus.Chloro(chloromethyl)dimethylsilane manufacturer Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23.Methyl N-(2-chlorophenyl)glycinate hydrochloride (1:1) supplier Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.1-fluoro-2-(trifluoromethoxy)benzene vendor The risk to the general public remains low. And we continue to be confident we are in a good position to respond to this developing situation.”Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.